as on November 28, 2025 at 11:29 pm IST
Day's Low
Day's High
0.58%
Downside
0.67%
Upside
52 Week's Low
52 Week's High
58.07%
Downside
2.55%
Upside
Check Roivant Sciences Ltd. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$14.5B
EPS (TTM)
-0.57
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.96%
PE Ratio (TTM)
1.88
Industry PE ratio
8.214070796460177
PEG Ratio
0EBITDA
-1.1B
Revenue (TTM)
20.3M
Profit Margin
0.00%
Return On Equity TTM
-17.36%
Track how Roivant Sciences Ltd. P/E has moved over time to understand its valuation trends.
Roivant Sciences Ltd. in the last 5 years
Lowest (-20.32x)
December 31, 2024
Today (1.88x)
November 29, 2025
Industry (8.21x)
November 29, 2025
Highest (-2.45x)
September 30, 2022
Today’s Price to Earnings Ratio: 1.88x
Compare market cap, revenue, PE, and other key metrics of Roivant Sciences Ltd. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $14.5B | NA | 1.88 | 0.00% | |
| BUY | $44.3B | 422.04% | -16.34 | -264.83% | |
| BUY | $58.8B | 247.47% | 1435.87 | 1.36% | |
| BUY | $110.8B | 91.26% | 30.39 | 31.35% | |
| BUY | $83.2B | 51.77% | 18.8 | 32.13% |
The Roivant Sciences Ltd. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Roivant Sciences Ltd. investment value today
Current value as on today
₹1,69,684
Returns
₹69,684
(+69.68%)
Returns from Roivant Sciences Ltd. Stock
₹63,808 (+63.81%)
Dollar Returns*
₹5,876 (+5.88%)
Based on 17 analysts
88.24%
Buy
11.76%
Hold
0.00%
Sell
Based on 17 analysts, 88.24% of analysts recommend a 'BUY' rating for Roivant Sciences Ltd.. Average target price of $24.55
Get share price movements and forecasts by analysts on Roivant Sciences Ltd..
What analysts predicted
15.19%UPSIDE
Target Price
$24.55
Current Price
$20.82
Analyzed by
17 Analysts
Target
$24.55
Roivant Sciences Ltd. target price $24.55, a slight upside of 15.19% compared to current price of $20.82. According to 17 analysts rating.
Search interest for Roivant Sciences Ltd. Stock has increased by 185% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:185% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 17 September
Wed, 09:30 PM
-Roivant Sciences stock rises 11% after positive Phase 3 trial results for brepocitinib in treating dermatomyositis.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 3 months, ROIV stock has moved up by 74.4%
Profit Spike
![]()
Netprofit is up for the last 2 quarters, -223.35M → -113.51M (in $), with an average increase of 96.8% per quarter
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 176.4% return, outperforming this stock by 112.7%
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 1047.3% return, outperforming this stock by 740.1%
Revenue Fall
![]()
Revenue is down for the last 4 quarters, 9.01M → 1.57M (in $), with an average decrease of 38.3% per quarter
| Organisation | Roivant Sciences Ltd. |
| Headquarters | 11-12 St. James's Square, London, United Kingdom, SW1Y 4LB |
| Industry | Financial |
| CEO | Mr. Matthew Gline |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Frank M. Torti M.B.A., M.D. | President & Vant Chair |
Dr. Huafeng Xu Ph.D. | Chief Technology Officer |
Mr. Ian Rosenblum | Chief Information Officer |
Mr. Josh Chen J.D. | General Counsel |
Mr. Matthew Gline | CEO & Director |
Dr. Mayukh Sukhatme M.D. | President, Chief Investment Officer & Director |
Ms. Jennifer Humes | Chief Accounting Officer |
Ms. Kelly Graff | Head of People |
Dr. Eric Venker M.D., Pharm.D. | President & CEO of Immunovant |
Mr. Richard Pulik | Chief Financial Officer |
Roivant Sciences Ltd. share price today is $20.82 as on at the close of the market. Roivant Sciences Ltd. share today touched a day high of $20.96 and a low of $20.7.
Roivant Sciences Ltd. share touched a 52 week high of $21.35 on and a 52 week low of $8.73 on . Roivant Sciences Ltd. stock price today i.e. is closed at $20.82,which is 2.48% down from its 52 week high and 138.49% up from its 52 week low.
Roivant Sciences Ltd. market capitalisation is $0.01T as on .
Indian investors can start investing in Roivant Sciences Ltd. (ROIV) shares with as little as ₹89.436 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹894.36 in Roivant Sciences Ltd. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Roivant Sciences Ltd. share’s latest price of $20.82 as on November 28, 2025 at 11:29 pm IST, you will get 0.4803 shares of Roivant Sciences Ltd.. Learn more about
fractional shares .